Favorable response to antigonadal therapy for a benign metastasizing leiomyoma.

Obstet Gynecol

From the Cardiovascular and Pulmonary Branch, National Heart, Lung, and Blood Institute, the Program in Reproductive and Adult Endocrinology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, and the Medical Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.

Published: February 2012

Background: Benign metastasizing leiomyoma and lymphangioleiomyomatosis (LAM) both are characterized by abnormal proliferation of smooth muscle-like cells in the lung.

Case: A 32-year-old African woman with a diagnosis of LAM underwent myomectomy for uterine leiomyomas. An alternative diagnosis of benign metastasizing leiomyoma was made on repeat lung biopsy. Treatment with leuprolide acetate decreased pulmonary infiltrates and improved lung function and exercise tolerance.

Conclusion: Accurately diagnosing benign metastasizing leiomyoma has important implications for clinical outcome. Because its clinical presentation may be misleading, immunohistochemical techniques may assist in differentiating benign metastasizing leiomyoma from LAM. This is important because, in benign metastasizing leiomyoma, reduced tumor burden and improved pulmonary function may be achieved by suppressing gonadal steroids.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3266540PMC
http://dx.doi.org/10.1097/AOG.0b013e318240090eDOI Listing

Publication Analysis

Top Keywords

benign metastasizing
24
metastasizing leiomyoma
24
benign
6
metastasizing
6
leiomyoma
6
favorable response
4
response antigonadal
4
antigonadal therapy
4
therapy benign
4
leiomyoma background
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!